Predicting the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma
This prognostic model can be used to predict and estimate the 1-year, 2-year, 3-year, and 5-year survival probability and median survival months of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma.
Research authors: Lei Huang, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Vesna Zadnik, Maja Primic-Žakelj, Margit Mägi, Robert Grützmann, Marc G.H. Besselink, Petra Schrotz-King, Hermann Brenner, Lina Jansen
Version: 2.7
  • Details
  • Save input
  • Load input

Calculate the result

Set more parameters to perform the calculation
Calculating......
Calculation error. Please check the model..

Conditional information

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This model is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying models Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
Evidencio v3.20 © 2015 - 2023 Evidencio. All Rights Reserved